aluates Reports

$ 0.0

Automative

Global Type 2 Diabetes Mellitus Treatment Market Research Report 2024

Published Date: September 2024

Report Code: QYRE-Auto-33T18099

BUY CHAPTERS

Global Type 2 Diabetes Mellitus Treatment Market Research Report 2024

Code: QYRE-Auto-33T18099

Report

September 2024

Pages:75

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Astrazeneca plc

Boehringer Ingelheim International GmbH

Daiichi Sankyo Co Ltd

Eli Lilly and Co

Merck& Co. Inc

Novartis

Novo Nordisk AS

Sanofi SA

Takeda Pharmaceutical Co Ltd

Type 2 Diabetes Mellitus Treatment Market Size

The global Type 2 Diabetes Mellitus Treatment market was valued at US$ 55430 million in 2023 and is anticipated to reach US$ 78630 million by 2030, witnessing a CAGR of 5.3% during the forecast period 2024-2030.

Type 2 Diabetes Mellitus Treatment Market

Type 2 diabetes mellitus treatment involves a combination of lifestyle changes, medications, and monitoring to manage blood glucose levels and prevent complications. Effective management of Type 2 diabetes mellitus involves a holistic approach combining lifestyle changes, medication, monitoring, and professional support to achieve and maintain optimal blood glucose control and overall health.

North American market for Type 2 Diabetes Mellitus Treatment is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Type 2 Diabetes Mellitus Treatment is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Type 2 Diabetes Mellitus Treatment in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Type 2 Diabetes Mellitus Treatment include AstraZeneca PLC, Boehringer Ingelheim International GmbH, Daiichi Sankyo Co. Ltd, Eli Lilly and Co., Merck & Co. Inc, Novartis AG, Novo Nordisk AS, Sanofi SA, Takeda Pharmaceutical Co. Ltd, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Type 2 Diabetes Mellitus Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Type 2 Diabetes Mellitus Treatment.

The Type 2 Diabetes Mellitus Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Type 2 Diabetes Mellitus Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Type 2 Diabetes Mellitus Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Type 2 Diabetes Mellitus Treatment Market Report

Report Metric	Details
Report Name	Type 2 Diabetes Mellitus Treatment Market
Accounted market size in 2023	US$ 55430 million
Forecasted market size in 2030	US$ 78630 million
CAGR	5.3%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Insulin DPP-4 Inhibitors GLP-1 Receptor Agonists SGLT2 Inhibitors Others
Segment by Application	Hospitals Clinics Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AstraZeneca PLC, Boehringer Ingelheim International GmbH, Daiichi Sankyo Co. Ltd, Eli Lilly and Co., Merck & Co. Inc, Novartis AG, Novo Nordisk AS, Sanofi SA, Takeda Pharmaceutical Co. Ltd
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Type 2 Diabetes Mellitus Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Type 2 Diabetes Mellitus Treatment Market growing?

Ans: The Type 2 Diabetes Mellitus Treatment Market witnessing a CAGR of 5.3% during the forecast period 2024-2030.

What is the Type 2 Diabetes Mellitus Treatment Market size in 2030?

Ans: The Type 2 Diabetes Mellitus Treatment Market size in 2030 will be US$ 78630 million.

Who are the main players in the Type 2 Diabetes Mellitus Treatment Market report?

Ans: The main players in the Type 2 Diabetes Mellitus Treatment Market are AstraZeneca PLC, Boehringer Ingelheim International GmbH, Daiichi Sankyo Co. Ltd, Eli Lilly and Co., Merck & Co. Inc, Novartis AG, Novo Nordisk AS, Sanofi SA, Takeda Pharmaceutical Co. Ltd

What are the Application segmentation covered in the Type 2 Diabetes Mellitus Treatment Market report?

Ans: The Applications covered in the Type 2 Diabetes Mellitus Treatment Market report are Hospitals, Clinics, Other

What are the Type segmentation covered in the Type 2 Diabetes Mellitus Treatment Market report?

Ans: The Types covered in the Type 2 Diabetes Mellitus Treatment Market report are Insulin, DPP-4 Inhibitors, GLP-1 Receptor Agonists, SGLT2 Inhibitors, Others

Recommended Reports

Diabetes Drug Markets

Diabetes Monitoring Devices

Diabetes Complications

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Type 2 Diabetes Mellitus Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Insulin

1.2.3 DPP-4 Inhibitors

1.2.4 GLP-1 Receptor Agonists

1.2.5 SGLT2 Inhibitors

1.2.6 Others

1.3 Market by Application

1.3.1 Global Type 2 Diabetes Mellitus Treatment Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Type 2 Diabetes Mellitus Treatment Market Perspective (2019-2030)

2.2 Global Type 2 Diabetes Mellitus Treatment Growth Trends by Region

2.2.1 Global Type 2 Diabetes Mellitus Treatment Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Type 2 Diabetes Mellitus Treatment Historic Market Size by Region (2019-2024)

2.2.3 Type 2 Diabetes Mellitus Treatment Forecasted Market Size by Region (2025-2030)

2.3 Type 2 Diabetes Mellitus Treatment Market Dynamics

2.3.1 Type 2 Diabetes Mellitus Treatment Industry Trends

2.3.2 Type 2 Diabetes Mellitus Treatment Market Drivers

2.3.3 Type 2 Diabetes Mellitus Treatment Market Challenges

2.3.4 Type 2 Diabetes Mellitus Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Type 2 Diabetes Mellitus Treatment Players by Revenue

3.1.1 Global Top Type 2 Diabetes Mellitus Treatment Players by Revenue (2019-2024)

3.1.2 Global Type 2 Diabetes Mellitus Treatment Revenue Market Share by Players (2019-2024)

3.2 Global Type 2 Diabetes Mellitus Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Type 2 Diabetes Mellitus Treatment Revenue

3.4 Global Type 2 Diabetes Mellitus Treatment Market Concentration Ratio

3.4.1 Global Type 2 Diabetes Mellitus Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Type 2 Diabetes Mellitus Treatment Revenue in 2023

3.5 Global Key Players of Type 2 Diabetes Mellitus Treatment Head office and Area Served

3.6 Global Key Players of Type 2 Diabetes Mellitus Treatment, Product and Application

3.7 Global Key Players of Type 2 Diabetes Mellitus Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Type 2 Diabetes Mellitus Treatment Breakdown Data by Type

4.1 Global Type 2 Diabetes Mellitus Treatment Historic Market Size by Type (2019-2024)

4.2 Global Type 2 Diabetes Mellitus Treatment Forecasted Market Size by Type (2025-2030)

5 Type 2 Diabetes Mellitus Treatment Breakdown Data by Application

5.1 Global Type 2 Diabetes Mellitus Treatment Historic Market Size by Application (2019-2024)

5.2 Global Type 2 Diabetes Mellitus Treatment Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Type 2 Diabetes Mellitus Treatment Market Size (2019-2030)

6.2 North America Type 2 Diabetes Mellitus Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Type 2 Diabetes Mellitus Treatment Market Size by Country (2019-2024)

6.4 North America Type 2 Diabetes Mellitus Treatment Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Type 2 Diabetes Mellitus Treatment Market Size (2019-2030)

7.2 Europe Type 2 Diabetes Mellitus Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Type 2 Diabetes Mellitus Treatment Market Size by Country (2019-2024)

7.4 Europe Type 2 Diabetes Mellitus Treatment Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Type 2 Diabetes Mellitus Treatment Market Size (2019-2030)

8.2 Asia-Pacific Type 2 Diabetes Mellitus Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Type 2 Diabetes Mellitus Treatment Market Size by Region (2019-2024)

8.4 Asia-Pacific Type 2 Diabetes Mellitus Treatment Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Type 2 Diabetes Mellitus Treatment Market Size (2019-2030)

9.2 Latin America Type 2 Diabetes Mellitus Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Type 2 Diabetes Mellitus Treatment Market Size by Country (2019-2024)

9.4 Latin America Type 2 Diabetes Mellitus Treatment Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Type 2 Diabetes Mellitus Treatment Market Size (2019-2030)

10.2 Middle East & Africa Type 2 Diabetes Mellitus Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Type 2 Diabetes Mellitus Treatment Market Size by Country (2019-2024)

10.4 Middle East & Africa Type 2 Diabetes Mellitus Treatment Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AstraZeneca PLC

11.1.1 AstraZeneca PLC Company Details

11.1.2 AstraZeneca PLC Business Overview

11.1.3 AstraZeneca PLC Type 2 Diabetes Mellitus Treatment Introduction

11.1.4 AstraZeneca PLC Revenue in Type 2 Diabetes Mellitus Treatment Business (2019-2024)

11.1.5 AstraZeneca PLC Recent Development

11.2 Boehringer Ingelheim International GmbH

11.2.1 Boehringer Ingelheim International GmbH Company Details

11.2.2 Boehringer Ingelheim International GmbH Business Overview

11.2.3 Boehringer Ingelheim International GmbH Type 2 Diabetes Mellitus Treatment Introduction

11.2.4 Boehringer Ingelheim International GmbH Revenue in Type 2 Diabetes Mellitus Treatment Business (2019-2024)

11.2.5 Boehringer Ingelheim International GmbH Recent Development

11.3 Daiichi Sankyo Co. Ltd

11.3.1 Daiichi Sankyo Co. Ltd Company Details

11.3.2 Daiichi Sankyo Co. Ltd Business Overview

11.3.3 Daiichi Sankyo Co. Ltd Type 2 Diabetes Mellitus Treatment Introduction

11.3.4 Daiichi Sankyo Co. Ltd Revenue in Type 2 Diabetes Mellitus Treatment Business (2019-2024)

11.3.5 Daiichi Sankyo Co. Ltd Recent Development

11.4 Eli Lilly and Co.

11.4.1 Eli Lilly and Co. Company Details

11.4.2 Eli Lilly and Co. Business Overview

11.4.3 Eli Lilly and Co. Type 2 Diabetes Mellitus Treatment Introduction

11.4.4 Eli Lilly and Co. Revenue in Type 2 Diabetes Mellitus Treatment Business (2019-2024)

11.4.5 Eli Lilly and Co. Recent Development

11.5 Merck & Co. Inc

11.5.1 Merck & Co. Inc Company Details

11.5.2 Merck & Co. Inc Business Overview

11.5.3 Merck & Co. Inc Type 2 Diabetes Mellitus Treatment Introduction

11.5.4 Merck & Co. Inc Revenue in Type 2 Diabetes Mellitus Treatment Business (2019-2024)

11.5.5 Merck & Co. Inc Recent Development

11.6 Novartis AG

11.6.1 Novartis AG Company Details

11.6.2 Novartis AG Business Overview

11.6.3 Novartis AG Type 2 Diabetes Mellitus Treatment Introduction

11.6.4 Novartis AG Revenue in Type 2 Diabetes Mellitus Treatment Business (2019-2024)

11.6.5 Novartis AG Recent Development

11.7 Novo Nordisk AS

11.7.1 Novo Nordisk AS Company Details

11.7.2 Novo Nordisk AS Business Overview

11.7.3 Novo Nordisk AS Type 2 Diabetes Mellitus Treatment Introduction

11.7.4 Novo Nordisk AS Revenue in Type 2 Diabetes Mellitus Treatment Business (2019-2024)

11.7.5 Novo Nordisk AS Recent Development

11.8 Sanofi SA

11.8.1 Sanofi SA Company Details

11.8.2 Sanofi SA Business Overview

11.8.3 Sanofi SA Type 2 Diabetes Mellitus Treatment Introduction

11.8.4 Sanofi SA Revenue in Type 2 Diabetes Mellitus Treatment Business (2019-2024)

11.8.5 Sanofi SA Recent Development

11.9 Takeda Pharmaceutical Co. Ltd

11.9.1 Takeda Pharmaceutical Co. Ltd Company Details

11.9.2 Takeda Pharmaceutical Co. Ltd Business Overview

11.9.3 Takeda Pharmaceutical Co. Ltd Type 2 Diabetes Mellitus Treatment Introduction

11.9.4 Takeda Pharmaceutical Co. Ltd Revenue in Type 2 Diabetes Mellitus Treatment Business (2019-2024)

11.9.5 Takeda Pharmaceutical Co. Ltd Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Astrazeneca plc

Boehringer Ingelheim International GmbH

Daiichi Sankyo Co Ltd

Eli Lilly and Co

Merck& Co. Inc

Novartis

Novo Nordisk AS

Sanofi SA

Takeda Pharmaceutical Co Ltd

List of Tables

Table 1. Global Type 2 Diabetes Mellitus Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Insulin

Table 3. Key Players of DPP-4 Inhibitors

Table 4. Key Players of GLP-1 Receptor Agonists

Table 5. Key Players of SGLT2 Inhibitors

Table 6. Key Players of Others

Table 7. Global Type 2 Diabetes Mellitus Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Type 2 Diabetes Mellitus Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Type 2 Diabetes Mellitus Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global Type 2 Diabetes Mellitus Treatment Market Share by Region (2019-2024)

Table 11. Global Type 2 Diabetes Mellitus Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global Type 2 Diabetes Mellitus Treatment Market Share by Region (2025-2030)

Table 13. Type 2 Diabetes Mellitus Treatment Market Trends

Table 14. Type 2 Diabetes Mellitus Treatment Market Drivers

Table 15. Type 2 Diabetes Mellitus Treatment Market Challenges

Table 16. Type 2 Diabetes Mellitus Treatment Market Restraints

Table 17. Global Type 2 Diabetes Mellitus Treatment Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global Type 2 Diabetes Mellitus Treatment Market Share by Players (2019-2024)

Table 19. Global Top Type 2 Diabetes Mellitus Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Type 2 Diabetes Mellitus Treatment as of 2023)

Table 20. Ranking of Global Top Type 2 Diabetes Mellitus Treatment Companies by Revenue (US$ Million) in 2023

Table 21. Global 5 Largest Players Market Share by Type 2 Diabetes Mellitus Treatment Revenue (CR5 and HHI) & (2019-2024)

Table 22. Global Key Players of Type 2 Diabetes Mellitus Treatment, Headquarters and Area Served

Table 23. Global Key Players of Type 2 Diabetes Mellitus Treatment, Product and Application

Table 24. Global Key Players of Type 2 Diabetes Mellitus Treatment, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Type 2 Diabetes Mellitus Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global Type 2 Diabetes Mellitus Treatment Revenue Market Share by Type (2019-2024)

Table 28. Global Type 2 Diabetes Mellitus Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global Type 2 Diabetes Mellitus Treatment Revenue Market Share by Type (2025-2030)

Table 30. Global Type 2 Diabetes Mellitus Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global Type 2 Diabetes Mellitus Treatment Revenue Market Share by Application (2019-2024)

Table 32. Global Type 2 Diabetes Mellitus Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global Type 2 Diabetes Mellitus Treatment Revenue Market Share by Application (2025-2030)

Table 34. North America Type 2 Diabetes Mellitus Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. North America Type 2 Diabetes Mellitus Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 36. North America Type 2 Diabetes Mellitus Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 37. Europe Type 2 Diabetes Mellitus Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Europe Type 2 Diabetes Mellitus Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 39. Europe Type 2 Diabetes Mellitus Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 40. Asia-Pacific Type 2 Diabetes Mellitus Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Asia-Pacific Type 2 Diabetes Mellitus Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 42. Asia-Pacific Type 2 Diabetes Mellitus Treatment Market Size by Region (2025-2030) & (US$ Million)

Table 43. Latin America Type 2 Diabetes Mellitus Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Latin America Type 2 Diabetes Mellitus Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 45. Latin America Type 2 Diabetes Mellitus Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 46. Middle East & Africa Type 2 Diabetes Mellitus Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 47. Middle East & Africa Type 2 Diabetes Mellitus Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 48. Middle East & Africa Type 2 Diabetes Mellitus Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 49. AstraZeneca PLC Company Details

Table 50. AstraZeneca PLC Business Overview

Table 51. AstraZeneca PLC Type 2 Diabetes Mellitus Treatment Product

Table 52. AstraZeneca PLC Revenue in Type 2 Diabetes Mellitus Treatment Business (2019-2024) & (US$ Million)

Table 53. AstraZeneca PLC Recent Development

Table 54. Boehringer Ingelheim International GmbH Company Details

Table 55. Boehringer Ingelheim International GmbH Business Overview

Table 56. Boehringer Ingelheim International GmbH Type 2 Diabetes Mellitus Treatment Product

Table 57. Boehringer Ingelheim International GmbH Revenue in Type 2 Diabetes Mellitus Treatment Business (2019-2024) & (US$ Million)

Table 58. Boehringer Ingelheim International GmbH Recent Development

Table 59. Daiichi Sankyo Co. Ltd Company Details

Table 60. Daiichi Sankyo Co. Ltd Business Overview

Table 61. Daiichi Sankyo Co. Ltd Type 2 Diabetes Mellitus Treatment Product

Table 62. Daiichi Sankyo Co. Ltd Revenue in Type 2 Diabetes Mellitus Treatment Business (2019-2024) & (US$ Million)

Table 63. Daiichi Sankyo Co. Ltd Recent Development

Table 64. Eli Lilly and Co. Company Details

Table 65. Eli Lilly and Co. Business Overview

Table 66. Eli Lilly and Co. Type 2 Diabetes Mellitus Treatment Product

Table 67. Eli Lilly and Co. Revenue in Type 2 Diabetes Mellitus Treatment Business (2019-2024) & (US$ Million)

Table 68. Eli Lilly and Co. Recent Development

Table 69. Merck & Co. Inc Company Details

Table 70. Merck & Co. Inc Business Overview

Table 71. Merck & Co. Inc Type 2 Diabetes Mellitus Treatment Product

Table 72. Merck & Co. Inc Revenue in Type 2 Diabetes Mellitus Treatment Business (2019-2024) & (US$ Million)

Table 73. Merck & Co. Inc Recent Development

Table 74. Novartis AG Company Details

Table 75. Novartis AG Business Overview

Table 76. Novartis AG Type 2 Diabetes Mellitus Treatment Product

Table 77. Novartis AG Revenue in Type 2 Diabetes Mellitus Treatment Business (2019-2024) & (US$ Million)

Table 78. Novartis AG Recent Development

Table 79. Novo Nordisk AS Company Details

Table 80. Novo Nordisk AS Business Overview

Table 81. Novo Nordisk AS Type 2 Diabetes Mellitus Treatment Product

Table 82. Novo Nordisk AS Revenue in Type 2 Diabetes Mellitus Treatment Business (2019-2024) & (US$ Million)

Table 83. Novo Nordisk AS Recent Development

Table 84. Sanofi SA Company Details

Table 85. Sanofi SA Business Overview

Table 86. Sanofi SA Type 2 Diabetes Mellitus Treatment Product

Table 87. Sanofi SA Revenue in Type 2 Diabetes Mellitus Treatment Business (2019-2024) & (US$ Million)

Table 88. Sanofi SA Recent Development

Table 89. Takeda Pharmaceutical Co. Ltd Company Details

Table 90. Takeda Pharmaceutical Co. Ltd Business Overview

Table 91. Takeda Pharmaceutical Co. Ltd Type 2 Diabetes Mellitus Treatment Product

Table 92. Takeda Pharmaceutical Co. Ltd Revenue in Type 2 Diabetes Mellitus Treatment Business (2019-2024) & (US$ Million)

Table 93. Takeda Pharmaceutical Co. Ltd Recent Development

Table 94. Research Programs/Design for This Report

Table 95. Key Data Information from Secondary Sources

Table 96. Key Data Information from Primary Sources

Table 97. Authors List of This Report

List of Figures

Figure 1. Type 2 Diabetes Mellitus Treatment Picture

Figure 2. Global Type 2 Diabetes Mellitus Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Type 2 Diabetes Mellitus Treatment Market Share by Type: 2023 VS 2030

Figure 4. Insulin Features

Figure 5. DPP-4 Inhibitors Features

Figure 6. GLP-1 Receptor Agonists Features

Figure 7. SGLT2 Inhibitors Features

Figure 8. Others Features

Figure 9. Global Type 2 Diabetes Mellitus Treatment Market Size by Application (2024-2030) & (US$ Million)

Figure 10. Global Type 2 Diabetes Mellitus Treatment Market Share by Application: 2023 VS 2030

Figure 11. Hospitals Case Studies

Figure 12. Clinics Case Studies

Figure 13. Other Case Studies

Figure 14. Type 2 Diabetes Mellitus Treatment Report Years Considered

Figure 15. Global Type 2 Diabetes Mellitus Treatment Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 16. Global Type 2 Diabetes Mellitus Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 17. Global Type 2 Diabetes Mellitus Treatment Market Share by Region: 2023 VS 2030

Figure 18. Global Type 2 Diabetes Mellitus Treatment Market Share by Players in 2023

Figure 19. Global Top Type 2 Diabetes Mellitus Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Type 2 Diabetes Mellitus Treatment as of 2023)

Figure 20. The Top 10 and 5 Players Market Share by Type 2 Diabetes Mellitus Treatment Revenue in 2023

Figure 21. North America Type 2 Diabetes Mellitus Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. North America Type 2 Diabetes Mellitus Treatment Market Share by Country (2019-2030)

Figure 23. United States Type 2 Diabetes Mellitus Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Type 2 Diabetes Mellitus Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Type 2 Diabetes Mellitus Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Type 2 Diabetes Mellitus Treatment Market Share by Country (2019-2030)

Figure 27. Germany Type 2 Diabetes Mellitus Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. France Type 2 Diabetes Mellitus Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. U.K. Type 2 Diabetes Mellitus Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Italy Type 2 Diabetes Mellitus Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Russia Type 2 Diabetes Mellitus Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Nordic Countries Type 2 Diabetes Mellitus Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Type 2 Diabetes Mellitus Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Asia-Pacific Type 2 Diabetes Mellitus Treatment Market Share by Region (2019-2030)

Figure 35. China Type 2 Diabetes Mellitus Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Japan Type 2 Diabetes Mellitus Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. South Korea Type 2 Diabetes Mellitus Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Southeast Asia Type 2 Diabetes Mellitus Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. India Type 2 Diabetes Mellitus Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Australia Type 2 Diabetes Mellitus Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Type 2 Diabetes Mellitus Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Latin America Type 2 Diabetes Mellitus Treatment Market Share by Country (2019-2030)

Figure 43. Mexico Type 2 Diabetes Mellitus Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Brazil Type 2 Diabetes Mellitus Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Type 2 Diabetes Mellitus Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa Type 2 Diabetes Mellitus Treatment Market Share by Country (2019-2030)

Figure 47. Turkey Type 2 Diabetes Mellitus Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Saudi Arabia Type 2 Diabetes Mellitus Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. UAE Type 2 Diabetes Mellitus Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. AstraZeneca PLC Revenue Growth Rate in Type 2 Diabetes Mellitus Treatment Business (2019-2024)

Figure 51. Boehringer Ingelheim International GmbH Revenue Growth Rate in Type 2 Diabetes Mellitus Treatment Business (2019-2024)

Figure 52. Daiichi Sankyo Co. Ltd Revenue Growth Rate in Type 2 Diabetes Mellitus Treatment Business (2019-2024)

Figure 53. Eli Lilly and Co. Revenue Growth Rate in Type 2 Diabetes Mellitus Treatment Business (2019-2024)

Figure 54. Merck & Co. Inc Revenue Growth Rate in Type 2 Diabetes Mellitus Treatment Business (2019-2024)

Figure 55. Novartis AG Revenue Growth Rate in Type 2 Diabetes Mellitus Treatment Business (2019-2024)

Figure 56. Novo Nordisk AS Revenue Growth Rate in Type 2 Diabetes Mellitus Treatment Business (2019-2024)

Figure 57. Sanofi SA Revenue Growth Rate in Type 2 Diabetes Mellitus Treatment Business (2019-2024)

Figure 58. Takeda Pharmaceutical Co. Ltd Revenue Growth Rate in Type 2 Diabetes Mellitus Treatment Business (2019-2024)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Type 2 Diabetes Medicines Market Research Report 2024

Type 2 Diabetes Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Diabetes Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Diabetes Mellitus Treatment Market Insights Forecast to 2030

Global Diabetes Management Products Market Insights Forecast to 2030

Global Hormonal Therapy for Type 2 Diabetes Market Research Report 2024

Global Diabetes Drugs Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Global Medication for Diabetes Market Research Report 2024

Diabetes Treatment Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Diabetes Management Equipment Market Research Report 2024

Blood Glucose Monitoring Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Diabetes Drug Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Injectable Drugs For Type 2 Diabete Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Diabetes Diet Market Research Report 2024

Global Hypoglycemic Drugs Market Insights Forecast to 2030

Next Generation Diabetes Therapy and Drug Delivery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pediatric Diabetes Therapeutic Market Research Report 2024

Global Drugs for Treating Metabolic Disorders Market Research Report 2024

Global Diabetes Care Drugs Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions